

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 6.74030056 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.61860487 |
| 3 | locomotory exploration behavior (GO:0035641) | 6.06186918 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.99882549 |
| 5 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.91413782 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 5.83981503 |
| 7 | glutamate secretion (GO:0014047) | 5.60020218 |
| 8 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.47181622 |
| 9 | vocalization behavior (GO:0071625) | 5.43119540 |
| 10 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.31364607 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.15524964 |
| 12 | cerebellar granule cell differentiation (GO:0021707) | 5.09370140 |
| 13 | neuronal action potential propagation (GO:0019227) | 4.96869762 |
| 14 | regulation of synaptic vesicle transport (GO:1902803) | 4.87163571 |
| 15 | neurotransmitter secretion (GO:0007269) | 4.86874133 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.86740646 |
| 17 | amino acid import (GO:0043090) | 4.76771521 |
| 18 | protein localization to synapse (GO:0035418) | 4.71771172 |
| 19 | cellular potassium ion homeostasis (GO:0030007) | 4.69271812 |
| 20 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.65020672 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.62696702 |
| 22 | exploration behavior (GO:0035640) | 4.54336365 |
| 23 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.52828166 |
| 24 | sodium ion export (GO:0071436) | 4.47122460 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 4.33630232 |
| 26 | gamma-aminobutyric acid transport (GO:0015812) | 4.24563572 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 4.22192637 |
| 28 | layer formation in cerebral cortex (GO:0021819) | 4.20396099 |
| 29 | long-term memory (GO:0007616) | 4.12944850 |
| 30 | glutamate receptor signaling pathway (GO:0007215) | 4.11742420 |
| 31 | central nervous system myelination (GO:0022010) | 4.10842487 |
| 32 | axon ensheathment in central nervous system (GO:0032291) | 4.10842487 |
| 33 | negative regulation of dendrite morphogenesis (GO:0050774) | 4.08329691 |
| 34 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.07790429 |
| 35 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.03355147 |
| 36 | regulation of synapse maturation (GO:0090128) | 4.01753675 |
| 37 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.00687848 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 4.00292448 |
| 39 | neuron cell-cell adhesion (GO:0007158) | 3.96501449 |
| 40 | neuromuscular process controlling posture (GO:0050884) | 3.95722966 |
| 41 | positive regulation of membrane potential (GO:0045838) | 3.95343199 |
| 42 | neurotransmitter transport (GO:0006836) | 3.94978812 |
| 43 | proline transport (GO:0015824) | 3.93644859 |
| 44 | dendritic spine morphogenesis (GO:0060997) | 3.90786371 |
| 45 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.89211398 |
| 46 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.85255062 |
| 47 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.83296711 |
| 48 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.78551895 |
| 49 | postsynaptic membrane organization (GO:0001941) | 3.75779691 |
| 50 | glycine transport (GO:0015816) | 3.72917968 |
| 51 | activation of protein kinase A activity (GO:0034199) | 3.72640590 |
| 52 | neuromuscular process controlling balance (GO:0050885) | 3.68914211 |
| 53 | regulation of neurotransmitter secretion (GO:0046928) | 3.66944541 |
| 54 | regulation of postsynaptic membrane potential (GO:0060078) | 3.64857787 |
| 55 | regulation of synaptic plasticity (GO:0048167) | 3.64413924 |
| 56 | regulation of neurotransmitter levels (GO:0001505) | 3.64369218 |
| 57 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.63915894 |
| 58 | positive regulation of synapse maturation (GO:0090129) | 3.63068991 |
| 59 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.62675333 |
| 60 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.59395986 |
| 61 | regulation of dendritic spine development (GO:0060998) | 3.59211283 |
| 62 | prepulse inhibition (GO:0060134) | 3.51013405 |
| 63 | cell communication by electrical coupling (GO:0010644) | 3.49616103 |
| 64 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.49273723 |
| 65 | neurotransmitter uptake (GO:0001504) | 3.48665694 |
| 66 | acidic amino acid transport (GO:0015800) | 3.48464342 |
| 67 | transmission of nerve impulse (GO:0019226) | 3.47559579 |
| 68 | membrane depolarization during action potential (GO:0086010) | 3.46349352 |
| 69 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.46003776 |
| 70 | dendritic spine organization (GO:0097061) | 3.45537044 |
| 71 | vesicle docking involved in exocytosis (GO:0006904) | 3.45152662 |
| 72 | regulation of neurotransmitter transport (GO:0051588) | 3.43851698 |
| 73 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.43081744 |
| 74 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.43054028 |
| 75 | regulation of vesicle fusion (GO:0031338) | 3.41424372 |
| 76 | long-term synaptic potentiation (GO:0060291) | 3.41403689 |
| 77 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.41352201 |
| 78 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.36599364 |
| 79 | positive regulation of neurotransmitter transport (GO:0051590) | 3.35098428 |
| 80 | membrane hyperpolarization (GO:0060081) | 3.31725373 |
| 81 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.31454777 |
| 82 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.29955871 |
| 83 | regulation of ARF protein signal transduction (GO:0032012) | 3.27511985 |
| 84 | auditory behavior (GO:0031223) | 3.26744693 |
| 85 | response to auditory stimulus (GO:0010996) | 3.26608500 |
| 86 | L-amino acid import (GO:0043092) | 3.26095553 |
| 87 | membrane depolarization (GO:0051899) | 3.25752667 |
| 88 | potassium ion import (GO:0010107) | 3.25706487 |
| 89 | potassium ion homeostasis (GO:0055075) | 3.23714823 |
| 90 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.23339973 |
| 91 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.21002138 |
| 92 | regulation of exocytosis (GO:0017157) | 3.20792849 |
| 93 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.20193263 |
| 94 | cell differentiation in hindbrain (GO:0021533) | 3.19946866 |
| 95 | neuromuscular synaptic transmission (GO:0007274) | 3.17439664 |
| 96 | vesicle docking (GO:0048278) | 3.15376501 |
| 97 | mating behavior (GO:0007617) | 3.13274565 |
| 98 | innervation (GO:0060384) | 3.12500363 |
| 99 | vesicle transport along microtubule (GO:0047496) | 3.11947039 |
| 100 | cellular sodium ion homeostasis (GO:0006883) | 3.11734065 |
| 101 | neuronal ion channel clustering (GO:0045161) | 3.10629924 |
| 102 | dicarboxylic acid transport (GO:0006835) | 3.09209978 |
| 103 | positive regulation of synaptic transmission (GO:0050806) | 3.08428546 |
| 104 | signal release (GO:0023061) | 3.08129057 |
| 105 | regulation of synaptic transmission (GO:0050804) | 3.07219796 |
| 106 | neuromuscular process (GO:0050905) | 3.06987821 |
| 107 | L-glutamate transport (GO:0015813) | 3.06649722 |
| 108 | synaptic transmission (GO:0007268) | 3.06423250 |
| 109 | cell communication involved in cardiac conduction (GO:0086065) | 3.06360618 |
| 110 | * synaptic vesicle endocytosis (GO:0048488) | 3.04802893 |
| 111 | learning (GO:0007612) | 3.02223367 |
| 112 | adult walking behavior (GO:0007628) | 3.01925740 |
| 113 | dendrite morphogenesis (GO:0048813) | 3.01604638 |
| 114 | neuron recognition (GO:0008038) | 3.01075688 |
| 115 | chemosensory behavior (GO:0007635) | 2.99550555 |
| 116 | cerebellar Purkinje cell layer development (GO:0021680) | 2.99410515 |
| 117 | detection of calcium ion (GO:0005513) | 2.99253186 |
| 118 | positive regulation of dendritic spine development (GO:0060999) | 2.98698496 |
| 119 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.98556616 |
| 120 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.97070931 |
| 121 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.96940437 |
| 122 | social behavior (GO:0035176) | 2.96290812 |
| 123 | intraspecies interaction between organisms (GO:0051703) | 2.96290812 |
| 124 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.94561065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.85684722 |
| 2 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10237481 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.08171797 |
| 4 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.04973871 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.99826766 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.95254851 |
| 7 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.94428921 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.83975731 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.80139793 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.80139793 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.72733180 |
| 12 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.63339080 |
| 13 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.61100305 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.54415113 |
| 15 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.52584871 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.47758023 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.46903517 |
| 18 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38548032 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.38349152 |
| 20 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.35327778 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.35024326 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.34727280 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.30035996 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.23319363 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.13555853 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.05705197 |
| 27 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.93364633 |
| 28 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.85885804 |
| 29 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.76851815 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76061430 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.67330574 |
| 32 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.55196268 |
| 33 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.50574882 |
| 34 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49598493 |
| 35 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.49166235 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.46602976 |
| 37 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.37256257 |
| 38 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35632340 |
| 39 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.35557056 |
| 40 | KDM2B_26808549_Chip-Seq_K562_Human | 1.35253386 |
| 41 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.31104825 |
| 42 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.28800637 |
| 43 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.27276851 |
| 44 | AR_19668381_ChIP-Seq_PC3_Human | 1.25607268 |
| 45 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24501215 |
| 46 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24223447 |
| 47 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22781916 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.22659033 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.21150329 |
| 50 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.21113620 |
| 51 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.20917466 |
| 52 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.19969095 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.18469112 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17070127 |
| 55 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.16988497 |
| 56 | * ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16765050 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.16056004 |
| 58 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.14943452 |
| 59 | STAT3_23295773_ChIP-Seq_U87_Human | 1.13515818 |
| 60 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.13434942 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.13348608 |
| 62 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.12562481 |
| 63 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11017135 |
| 64 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.10290054 |
| 65 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.09718912 |
| 66 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.09059029 |
| 67 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.08661438 |
| 68 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.08028961 |
| 69 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.07328965 |
| 70 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.06995929 |
| 71 | * OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.06832303 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.05184458 |
| 73 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.04373250 |
| 74 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01282860 |
| 75 | P300_19829295_ChIP-Seq_ESCs_Human | 1.01281751 |
| 76 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 1.00772363 |
| 77 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.99560567 |
| 78 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98610139 |
| 79 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98153255 |
| 80 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98089472 |
| 81 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.97756262 |
| 82 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97135799 |
| 83 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.95913153 |
| 84 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.95883638 |
| 85 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.94664089 |
| 86 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94518767 |
| 87 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94238729 |
| 88 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.93088966 |
| 89 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92974447 |
| 90 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.92814883 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.92598207 |
| 92 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.92533696 |
| 93 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92498552 |
| 94 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.92076019 |
| 95 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91947333 |
| 96 | * SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.91126625 |
| 97 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91036370 |
| 98 | * SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.90563959 |
| 99 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88736116 |
| 100 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88385097 |
| 101 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.88329965 |
| 102 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87988294 |
| 103 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.87977008 |
| 104 | P68_20966046_ChIP-Seq_HELA_Human | 0.87677968 |
| 105 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.87671237 |
| 106 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87353827 |
| 107 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.87283876 |
| 108 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87116197 |
| 109 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86734969 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.86125847 |
| 111 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85606731 |
| 112 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.84855534 |
| 113 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84459075 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.84217606 |
| 115 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84112528 |
| 116 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84025321 |
| 117 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.82841929 |
| 118 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.82771698 |
| 119 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.82624259 |
| 120 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 0.81187634 |
| 121 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81086188 |
| 122 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.78909043 |
| 123 | RXR_22108803_ChIP-Seq_LS180_Human | 0.78900086 |
| 124 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78764733 |
| 125 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.78467062 |
| 126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.77542289 |
| 127 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.77107335 |
| 128 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.72840408 |
| 129 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.71564603 |
| 130 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.71199382 |
| 131 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.69622872 |
| 132 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.68699169 |
| 133 | SA1_27219007_Chip-Seq_Bcells_Human | 0.67794813 |
| 134 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.66067289 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.90824116 |
| 2 | MP0003880_abnormal_central_pattern | 4.65631212 |
| 3 | MP0003635_abnormal_synaptic_transmissio | 4.29371508 |
| 4 | MP0004270_analgesia | 3.74248810 |
| 5 | MP0009745_abnormal_behavioral_response | 3.47281526 |
| 6 | MP0009046_muscle_twitch | 3.41656159 |
| 7 | MP0002064_seizures | 3.32163226 |
| 8 | MP0002063_abnormal_learning/memory/cond | 3.31117519 |
| 9 | MP0001968_abnormal_touch/_nociception | 3.17291802 |
| 10 | MP0002822_catalepsy | 3.09362197 |
| 11 | MP0005423_abnormal_somatic_nervous | 3.06729438 |
| 12 | MP0002272_abnormal_nervous_system | 2.80358432 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.75874956 |
| 14 | MP0002734_abnormal_mechanical_nocicepti | 2.74348870 |
| 15 | MP0001486_abnormal_startle_reflex | 2.64969780 |
| 16 | MP0002736_abnormal_nociception_after | 2.38092954 |
| 17 | MP0001501_abnormal_sleep_pattern | 2.37537629 |
| 18 | MP0008569_lethality_at_weaning | 2.24901289 |
| 19 | MP0002735_abnormal_chemical_nociception | 2.24724589 |
| 20 | MP0002733_abnormal_thermal_nociception | 2.07308297 |
| 21 | MP0001970_abnormal_pain_threshold | 2.05166295 |
| 22 | MP0002067_abnormal_sensory_capabilities | 2.02103828 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.97088656 |
| 24 | MP0002909_abnormal_adrenal_gland | 1.90362411 |
| 25 | MP0003329_amyloid_beta_deposits | 1.86987402 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 1.84451532 |
| 27 | MP0004858_abnormal_nervous_system | 1.83658369 |
| 28 | MP0004811_abnormal_neuron_physiology | 1.83265625 |
| 29 | MP0002184_abnormal_innervation | 1.77412868 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.68495425 |
| 31 | MP0005386_behavior/neurological_phenoty | 1.68386346 |
| 32 | MP0004924_abnormal_behavior | 1.68386346 |
| 33 | MP0003879_abnormal_hair_cell | 1.64588971 |
| 34 | MP0005646_abnormal_pituitary_gland | 1.61525317 |
| 35 | MP0000955_abnormal_spinal_cord | 1.57425163 |
| 36 | MP0004885_abnormal_endolymph | 1.55112477 |
| 37 | MP0003123_paternal_imprinting | 1.55043309 |
| 38 | MP0001984_abnormal_olfaction | 1.54174607 |
| 39 | MP0003633_abnormal_nervous_system | 1.47269519 |
| 40 | MP0003787_abnormal_imprinting | 1.45363366 |
| 41 | MP0002882_abnormal_neuron_morphology | 1.45222453 |
| 42 | MP0006276_abnormal_autonomic_nervous | 1.44868233 |
| 43 | MP0002066_abnormal_motor_capabilities/c | 1.44518586 |
| 44 | MP0000778_abnormal_nervous_system | 1.42984942 |
| 45 | MP0005551_abnormal_eye_electrophysiolog | 1.41354176 |
| 46 | MP0001502_abnormal_circadian_rhythm | 1.37687896 |
| 47 | MP0004142_abnormal_muscle_tone | 1.34463348 |
| 48 | MP0003631_nervous_system_phenotype | 1.21235978 |
| 49 | MP0008872_abnormal_physiological_respon | 1.17196705 |
| 50 | MP0002229_neurodegeneration | 1.16330815 |
| 51 | MP0005645_abnormal_hypothalamus_physiol | 1.15282469 |
| 52 | MP0001905_abnormal_dopamine_level | 1.14077296 |
| 53 | MP0004145_abnormal_muscle_electrophysio | 1.08857433 |
| 54 | MP0001529_abnormal_vocalization | 1.06312253 |
| 55 | MP0001346_abnormal_lacrimal_gland | 1.05427862 |
| 56 | MP0003075_altered_response_to | 1.04506604 |
| 57 | MP0002152_abnormal_brain_morphology | 1.03662830 |
| 58 | MP0003122_maternal_imprinting | 1.01570460 |
| 59 | MP0008961_abnormal_basal_metabolism | 0.99297196 |
| 60 | MP0008874_decreased_physiological_sensi | 0.98400581 |
| 61 | MP0002090_abnormal_vision | 0.98222323 |
| 62 | MP0004147_increased_porphyrin_level | 0.97458955 |
| 63 | MP0003690_abnormal_glial_cell | 0.97036056 |
| 64 | MP0000751_myopathy | 0.96305333 |
| 65 | MP0003283_abnormal_digestive_organ | 0.95233060 |
| 66 | MP0002069_abnormal_eating/drinking_beha | 0.93068622 |
| 67 | MP0000920_abnormal_myelination | 0.92090432 |
| 68 | MP0001348_abnormal_lacrimal_gland | 0.91768589 |
| 69 | MP0000569_abnormal_digit_pigmentation | 0.90265675 |
| 70 | MP0001177_atelectasis | 0.90132203 |
| 71 | MP0000013_abnormal_adipose_tissue | 0.90011577 |
| 72 | MP0003634_abnormal_glial_cell | 0.88909034 |
| 73 | MP0005535_abnormal_body_temperature | 0.87076946 |
| 74 | MP0003632_abnormal_nervous_system | 0.85467293 |
| 75 | MP0005394_taste/olfaction_phenotype | 0.84031523 |
| 76 | MP0005499_abnormal_olfactory_system | 0.84031523 |
| 77 | MP0004742_abnormal_vestibular_system | 0.83480691 |
| 78 | MP0000604_amyloidosis | 0.82385748 |
| 79 | MP0010386_abnormal_urinary_bladder | 0.80880750 |
| 80 | MP0006072_abnormal_retinal_apoptosis | 0.79797935 |
| 81 | MP0001986_abnormal_taste_sensitivity | 0.78164121 |
| 82 | MP0001188_hyperpigmentation | 0.77829692 |
| 83 | MP0004085_abnormal_heartbeat | 0.77355528 |
| 84 | MP0002752_abnormal_somatic_nervous | 0.77333460 |
| 85 | MP0004233_abnormal_muscle_weight | 0.76923885 |
| 86 | MP0005167_abnormal_blood-brain_barrier | 0.75520199 |
| 87 | MP0001963_abnormal_hearing_physiology | 0.74882815 |
| 88 | MP0004043_abnormal_pH_regulation | 0.68811604 |
| 89 | MP0004215_abnormal_myocardial_fiber | 0.67754498 |
| 90 | MP0003172_abnormal_lysosome_physiology | 0.67664732 |
| 91 | MP0008877_abnormal_DNA_methylation | 0.67354238 |
| 92 | MP0004510_myositis | 0.66491922 |
| 93 | MP0002638_abnormal_pupillary_reflex | 0.65632095 |
| 94 | MP0005253_abnormal_eye_physiology | 0.64776569 |
| 95 | MP0004130_abnormal_muscle_cell | 0.64137493 |
| 96 | MP0003137_abnormal_impulse_conducting | 0.63581998 |
| 97 | MP0000631_abnormal_neuroendocrine_gland | 0.62555898 |
| 98 | MP0005623_abnormal_meninges_morphology | 0.60796195 |
| 99 | MP0005166_decreased_susceptibility_to | 0.60727156 |
| 100 | MP0001485_abnormal_pinna_reflex | 0.60075202 |
| 101 | MP0000579_abnormal_nail_morphology | 0.58342335 |
| 102 | MP0010769_abnormal_survival | 0.54046734 |
| 103 | MP0001664_abnormal_digestion | 0.53677309 |
| 104 | MP0004484_altered_response_of | 0.53291811 |
| 105 | MP0010234_abnormal_vibrissa_follicle | 0.52929539 |
| 106 | MP0001943_abnormal_respiration | 0.52037016 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.51402034 |
| 108 | MP0003956_abnormal_body_size | 0.50928933 |
| 109 | MP0010768_mortality/aging | 0.50734809 |
| 110 | MP0002082_postnatal_lethality | 0.47533947 |
| 111 | MP0010770_preweaning_lethality | 0.47533947 |
| 112 | MP0002873_normal_phenotype | 0.46516532 |
| 113 | MP0003183_abnormal_peptide_metabolism | 0.45870067 |
| 114 | MP0003045_fibrosis | 0.45724083 |
| 115 | MP0002169_no_abnormal_phenotype | 0.44897009 |
| 116 | MP0001765_abnormal_ion_homeostasis | 0.44456964 |
| 117 | MP0005409_darkened_coat_color | 0.40543959 |
| 118 | MP0001731_abnormal_postnatal_growth | 0.40068491 |
| 119 | MP0002089_abnormal_postnatal_growth/wei | 0.39798505 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 7.72209679 |
| 2 | Focal motor seizures (HP:0011153) | 7.46280341 |
| 3 | Focal seizures (HP:0007359) | 5.84077379 |
| 4 | Visual hallucinations (HP:0002367) | 5.73578140 |
| 5 | Progressive cerebellar ataxia (HP:0002073) | 4.85421507 |
| 6 | Action tremor (HP:0002345) | 4.83033853 |
| 7 | Epileptic encephalopathy (HP:0200134) | 4.69602491 |
| 8 | Febrile seizures (HP:0002373) | 4.65188977 |
| 9 | Atonic seizures (HP:0010819) | 4.63335424 |
| 10 | Absence seizures (HP:0002121) | 4.25784163 |
| 11 | Generalized tonic-clonic seizures (HP:0002069) | 3.95120482 |
| 12 | Supranuclear gaze palsy (HP:0000605) | 3.88940177 |
| 13 | Ankle clonus (HP:0011448) | 3.84125636 |
| 14 | Dialeptic seizures (HP:0011146) | 3.83198860 |
| 15 | Cerebral hypomyelination (HP:0006808) | 3.71125691 |
| 16 | Gaze-evoked nystagmus (HP:0000640) | 3.64122385 |
| 17 | Depression (HP:0000716) | 3.58767715 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.57538343 |
| 19 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.47114572 |
| 20 | Dysmetria (HP:0001310) | 3.41706901 |
| 21 | Poor eye contact (HP:0000817) | 3.39229925 |
| 22 | Postural instability (HP:0002172) | 3.29202663 |
| 23 | Broad-based gait (HP:0002136) | 3.26679930 |
| 24 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.23768786 |
| 25 | Anxiety (HP:0000739) | 3.19323203 |
| 26 | Abnormality of the lower motor neuron (HP:0002366) | 3.17645510 |
| 27 | Truncal ataxia (HP:0002078) | 3.16352186 |
| 28 | Impaired social interactions (HP:0000735) | 3.11562237 |
| 29 | Abnormal social behavior (HP:0012433) | 3.11562237 |
| 30 | Mutism (HP:0002300) | 3.07808168 |
| 31 | Ventricular fibrillation (HP:0001663) | 3.04759520 |
| 32 | Abnormal eating behavior (HP:0100738) | 3.03859397 |
| 33 | Impaired smooth pursuit (HP:0007772) | 3.00533487 |
| 34 | Hemiplegia (HP:0002301) | 2.99417222 |
| 35 | Papilledema (HP:0001085) | 2.97253528 |
| 36 | Genetic anticipation (HP:0003743) | 2.93957465 |
| 37 | Akinesia (HP:0002304) | 2.90628314 |
| 38 | Scanning speech (HP:0002168) | 2.87638806 |
| 39 | Intention tremor (HP:0002080) | 2.87025920 |
| 40 | Urinary urgency (HP:0000012) | 2.82764090 |
| 41 | Torticollis (HP:0000473) | 2.81571996 |
| 42 | Spastic gait (HP:0002064) | 2.79265254 |
| 43 | Dysmetric saccades (HP:0000641) | 2.75708123 |
| 44 | Apathy (HP:0000741) | 2.74296552 |
| 45 | Hemiparesis (HP:0001269) | 2.73013092 |
| 46 | Annular pancreas (HP:0001734) | 2.71649060 |
| 47 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.68743995 |
| 48 | Amblyopia (HP:0000646) | 2.62288150 |
| 49 | Focal dystonia (HP:0004373) | 2.62129935 |
| 50 | Bradykinesia (HP:0002067) | 2.61590343 |
| 51 | Sleep apnea (HP:0010535) | 2.56281723 |
| 52 | Progressive inability to walk (HP:0002505) | 2.55281954 |
| 53 | Peripheral hypomyelination (HP:0007182) | 2.54962844 |
| 54 | Status epilepticus (HP:0002133) | 2.50221771 |
| 55 | Diplopia (HP:0000651) | 2.49519325 |
| 56 | Abnormality of binocular vision (HP:0011514) | 2.49519325 |
| 57 | Diminished motivation (HP:0000745) | 2.45840516 |
| 58 | Stereotypic behavior (HP:0000733) | 2.41496670 |
| 59 | Spastic tetraparesis (HP:0001285) | 2.39549843 |
| 60 | Choreoathetosis (HP:0001266) | 2.38119532 |
| 61 | Impaired vibratory sensation (HP:0002495) | 2.35669180 |
| 62 | Megalencephaly (HP:0001355) | 2.34957585 |
| 63 | Pointed chin (HP:0000307) | 2.31812279 |
| 64 | Craniofacial dystonia (HP:0012179) | 2.31576639 |
| 65 | Insomnia (HP:0100785) | 2.30468479 |
| 66 | Neurofibrillary tangles (HP:0002185) | 2.27140283 |
| 67 | Hyperventilation (HP:0002883) | 2.26821904 |
| 68 | CNS hypomyelination (HP:0003429) | 2.24435664 |
| 69 | Bundle branch block (HP:0011710) | 2.24088756 |
| 70 | Lower limb muscle weakness (HP:0007340) | 2.23233795 |
| 71 | Central scotoma (HP:0000603) | 2.22472847 |
| 72 | Epileptiform EEG discharges (HP:0011182) | 2.19775071 |
| 73 | Pheochromocytoma (HP:0002666) | 2.19564631 |
| 74 | Clonus (HP:0002169) | 2.19230497 |
| 75 | Drooling (HP:0002307) | 2.18715368 |
| 76 | Excessive salivation (HP:0003781) | 2.18715368 |
| 77 | EEG with generalized epileptiform discharges (HP:0011198) | 2.16229334 |
| 78 | Insidious onset (HP:0003587) | 2.13630094 |
| 79 | Termporal pattern (HP:0011008) | 2.13630094 |
| 80 | Cerebral inclusion bodies (HP:0100314) | 2.13136947 |
| 81 | Fetal akinesia sequence (HP:0001989) | 2.12200035 |
| 82 | Abnormality of saccadic eye movements (HP:0000570) | 2.08781883 |
| 83 | Generalized myoclonic seizures (HP:0002123) | 2.05588130 |
| 84 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.05083520 |
| 85 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.05083520 |
| 86 | Gait ataxia (HP:0002066) | 2.05050120 |
| 87 | Tetraplegia (HP:0002445) | 2.03877725 |
| 88 | Hypsarrhythmia (HP:0002521) | 2.03163098 |
| 89 | Neuronal loss in central nervous system (HP:0002529) | 2.02564906 |
| 90 | Lower limb amyotrophy (HP:0007210) | 2.02258037 |
| 91 | Incomplete penetrance (HP:0003829) | 2.02015180 |
| 92 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.00731527 |
| 93 | Limb dystonia (HP:0002451) | 1.99371614 |
| 94 | Abnormality of the corticospinal tract (HP:0002492) | 1.97811590 |
| 95 | Abnormal EKG (HP:0003115) | 1.97668494 |
| 96 | Agitation (HP:0000713) | 1.97077231 |
| 97 | Rigidity (HP:0002063) | 1.96017662 |
| 98 | Increased circulating renin level (HP:0000848) | 1.94253460 |
| 99 | Memory impairment (HP:0002354) | 1.93953749 |
| 100 | Absent speech (HP:0001344) | 1.93222562 |
| 101 | Resting tremor (HP:0002322) | 1.90949430 |
| 102 | Congenital stationary night blindness (HP:0007642) | 1.89091647 |
| 103 | Delusions (HP:0000746) | 1.88366592 |
| 104 | Neuroendocrine neoplasm (HP:0100634) | 1.87943878 |
| 105 | Heart block (HP:0012722) | 1.83666431 |
| 106 | Abnormality of macular pigmentation (HP:0008002) | 1.83625315 |
| 107 | Rapidly progressive (HP:0003678) | 1.83428908 |
| 108 | Psychosis (HP:0000709) | 1.83403104 |
| 109 | Slow saccadic eye movements (HP:0000514) | 1.83303531 |
| 110 | Aplasia involving bones of the extremities (HP:0009825) | 1.82496414 |
| 111 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.82496414 |
| 112 | Aplasia of the phalanges of the hand (HP:0009802) | 1.82496414 |
| 113 | Dementia (HP:0000726) | 1.82081341 |
| 114 | Postural tremor (HP:0002174) | 1.81872453 |
| 115 | Polyphagia (HP:0002591) | 1.81402569 |
| 116 | Split foot (HP:0001839) | 1.81318211 |
| 117 | Lower limb asymmetry (HP:0100559) | 1.81116101 |
| 118 | Inability to walk (HP:0002540) | 1.81103568 |
| 119 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.79070822 |
| 120 | Obstructive sleep apnea (HP:0002870) | 1.78725691 |
| 121 | Bronchomalacia (HP:0002780) | 1.78570386 |
| 122 | Spinal canal stenosis (HP:0003416) | 1.77540782 |
| 123 | Prolonged QT interval (HP:0001657) | 1.74846790 |
| 124 | Limb ataxia (HP:0002070) | 1.73434994 |
| 125 | Iris hypopigmentation (HP:0007730) | 1.73160887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.52405111 |
| 2 | MAP3K9 | 4.24537301 |
| 3 | EPHA4 | 4.15895382 |
| 4 | MAP3K4 | 2.98052253 |
| 5 | MINK1 | 2.81697310 |
| 6 | DAPK2 | 2.70629854 |
| 7 | PRKD3 | 2.55571516 |
| 8 | KSR2 | 2.45175170 |
| 9 | MAP2K7 | 2.30971758 |
| 10 | MARK1 | 2.22945915 |
| 11 | CAMKK1 | 2.19511793 |
| 12 | NTRK2 | 2.04183928 |
| 13 | NTRK1 | 1.99698660 |
| 14 | RIPK4 | 1.93178515 |
| 15 | STK38 | 1.91610593 |
| 16 | MAP2K4 | 1.90211371 |
| 17 | MAP3K12 | 1.80817277 |
| 18 | CDK5 | 1.61077151 |
| 19 | ARAF | 1.58128775 |
| 20 | GRK5 | 1.56494065 |
| 21 | DAPK1 | 1.51395645 |
| 22 | MAP3K13 | 1.49445888 |
| 23 | PRPF4B | 1.44993186 |
| 24 | CDK19 | 1.39850804 |
| 25 | KSR1 | 1.39715983 |
| 26 | * PAK6 | 1.35942135 |
| 27 | CAMKK2 | 1.31634723 |
| 28 | FES | 1.30688016 |
| 29 | TAOK1 | 1.28301376 |
| 30 | SIK2 | 1.26655129 |
| 31 | MAP3K2 | 1.26578067 |
| 32 | TYRO3 | 1.26415590 |
| 33 | UHMK1 | 1.26013639 |
| 34 | TNIK | 1.24791786 |
| 35 | PINK1 | 1.22534719 |
| 36 | PRKCG | 1.22346149 |
| 37 | PLK2 | 1.18030191 |
| 38 | CAMK1 | 1.09877807 |
| 39 | PRKCH | 1.09160516 |
| 40 | PNCK | 1.07927612 |
| 41 | SGK494 | 0.99899540 |
| 42 | SGK223 | 0.99899540 |
| 43 | STK11 | 0.99471054 |
| 44 | LMTK2 | 0.98953803 |
| 45 | ALK | 0.98424597 |
| 46 | TNK2 | 0.98119741 |
| 47 | MAPK13 | 0.97130141 |
| 48 | CDK15 | 0.94745859 |
| 49 | CDK18 | 0.94313448 |
| 50 | PHKG1 | 0.91398543 |
| 51 | PHKG2 | 0.91398543 |
| 52 | LATS2 | 0.90524134 |
| 53 | MAPK12 | 0.90298553 |
| 54 | RET | 0.90280678 |
| 55 | CAMK2A | 0.89353725 |
| 56 | RIPK1 | 0.89139200 |
| 57 | CDK14 | 0.89138076 |
| 58 | RAF1 | 0.87296767 |
| 59 | CDK11A | 0.83318944 |
| 60 | PDK1 | 0.80021741 |
| 61 | CASK | 0.79427154 |
| 62 | SGK3 | 0.79067344 |
| 63 | NEK1 | 0.78072518 |
| 64 | WNK1 | 0.78045289 |
| 65 | SGK2 | 0.77777117 |
| 66 | MAP3K11 | 0.77594539 |
| 67 | MAP3K1 | 0.76123227 |
| 68 | LIMK1 | 0.71992248 |
| 69 | PAK3 | 0.71092531 |
| 70 | PDPK1 | 0.69070073 |
| 71 | DYRK1A | 0.68749200 |
| 72 | CAMK2B | 0.67512804 |
| 73 | SGK1 | 0.65913127 |
| 74 | MARK2 | 0.65879748 |
| 75 | OXSR1 | 0.64418785 |
| 76 | PTK2B | 0.63623346 |
| 77 | CDC42BPA | 0.63411987 |
| 78 | PKN1 | 0.61588938 |
| 79 | MAP3K7 | 0.58198665 |
| 80 | BMPR2 | 0.57741996 |
| 81 | BRSK1 | 0.57118580 |
| 82 | NEK6 | 0.56225032 |
| 83 | RPS6KA3 | 0.56205192 |
| 84 | TESK1 | 0.55478036 |
| 85 | CAMK4 | 0.54623960 |
| 86 | SCYL2 | 0.52693021 |
| 87 | MAPK10 | 0.51955737 |
| 88 | CAMK2G | 0.51390462 |
| 89 | CAMK1G | 0.49381807 |
| 90 | PRKCZ | 0.47651391 |
| 91 | CSNK1G2 | 0.47367873 |
| 92 | CAMK2D | 0.46012620 |
| 93 | FGFR2 | 0.45999253 |
| 94 | FYN | 0.45998176 |
| 95 | PRKG2 | 0.45148848 |
| 96 | DAPK3 | 0.43610327 |
| 97 | MAP2K1 | 0.37776223 |
| 98 | FER | 0.36605418 |
| 99 | PRKD2 | 0.35416745 |
| 100 | MAPKAPK5 | 0.35369448 |
| 101 | IRAK2 | 0.34318906 |
| 102 | ROCK2 | 0.34203336 |
| 103 | PRKCE | 0.33998937 |
| 104 | PRKCB | 0.33708215 |
| 105 | MAP2K6 | 0.33478755 |
| 106 | NME1 | 0.32840910 |
| 107 | PRKCA | 0.30651118 |
| 108 | ERBB2 | 0.30332682 |
| 109 | ROCK1 | 0.29318583 |
| 110 | CCNB1 | 0.28155972 |
| 111 | BRAF | 0.28117835 |
| 112 | DMPK | 0.28019213 |
| 113 | MAPK8 | 0.27696267 |
| 114 | JAK2 | 0.27187306 |
| 115 | TAOK2 | 0.26312432 |
| 116 | SRC | 0.23887500 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.54389686 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.53326620 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.83996030 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.78722814 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.68806613 |
| 6 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.61418695 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.58705980 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.58166446 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.51051220 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.42548108 |
| 11 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.34526110 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.23012195 |
| 13 | Insulin secretion_Homo sapiens_hsa04911 | 2.12596631 |
| 14 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.10811545 |
| 15 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.96302521 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.92948381 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.89975670 |
| 18 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.81492327 |
| 19 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.73058822 |
| 20 | Taste transduction_Homo sapiens_hsa04742 | 1.68368468 |
| 21 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.64959552 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.63017751 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.58587669 |
| 24 | Cocaine addiction_Homo sapiens_hsa05030 | 1.56683719 |
| 25 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.56242400 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.54086228 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.53333002 |
| 28 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.53144272 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.52070761 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.51652293 |
| 31 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.48346526 |
| 32 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.35749701 |
| 33 | Gap junction_Homo sapiens_hsa04540 | 1.30270949 |
| 34 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.28249048 |
| 35 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27931718 |
| 36 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.26773825 |
| 37 | Phototransduction_Homo sapiens_hsa04744 | 1.24982612 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.24807900 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.12122277 |
| 40 | Glioma_Homo sapiens_hsa05214 | 1.09773825 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.03057416 |
| 42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.01271024 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.97541043 |
| 44 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.96071957 |
| 45 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.95740712 |
| 46 | Melanogenesis_Homo sapiens_hsa04916 | 0.94700405 |
| 47 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92711098 |
| 48 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.90874116 |
| 49 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.90388784 |
| 50 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.88403511 |
| 51 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.88252177 |
| 52 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.86761846 |
| 53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84221623 |
| 54 | Axon guidance_Homo sapiens_hsa04360 | 0.78211087 |
| 55 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.77954316 |
| 56 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.73221569 |
| 57 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.72706370 |
| 58 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.72494060 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.71862524 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.70448380 |
| 61 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.66155867 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.65483107 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65387854 |
| 64 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62360191 |
| 65 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.62047887 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.61479993 |
| 67 | Bile secretion_Homo sapiens_hsa04976 | 0.61253229 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.59571026 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.58845282 |
| 70 | Endocytosis_Homo sapiens_hsa04144 | 0.58537283 |
| 71 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.56361379 |
| 72 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53660106 |
| 73 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53027955 |
| 74 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.52354253 |
| 75 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52335291 |
| 76 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52013236 |
| 77 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52000587 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.46166673 |
| 79 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.46051073 |
| 80 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.45650344 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.44561212 |
| 82 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.44192300 |
| 83 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.43979477 |
| 84 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43735013 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.43351064 |
| 86 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.40779616 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.39721595 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39415816 |
| 89 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39285228 |
| 90 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38909775 |
| 91 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38285202 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.37133024 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.36090531 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36053235 |
| 95 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.35366468 |
| 96 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.32261435 |
| 97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.32026820 |
| 98 | Mineral absorption_Homo sapiens_hsa04978 | 0.31668779 |
| 99 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.31583372 |
| 100 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.31377593 |
| 101 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.30886834 |
| 102 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.30870841 |
| 103 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.30169854 |
| 104 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29801416 |
| 105 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.27263462 |
| 106 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.26931161 |
| 107 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.26717361 |
| 108 | Alzheimers disease_Homo sapiens_hsa05010 | 0.22905867 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.22201905 |
| 110 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.20589264 |
| 111 | Tight junction_Homo sapiens_hsa04530 | 0.20472487 |
| 112 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.18228143 |
| 113 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.17983714 |
| 114 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.17338385 |

